Trial
NCT04942340
Turning Dexmedetomidine Into a Powerful Anesthetic That Can be Rapidly and Completely Reversed
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Chicago
Collaborators
—
Condition
Emergence From Anesthesia
Intervention
Atipamezole & Caffeine
Why stopped
Withdrawn secondary to a change in protocol design forthcoming.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-05-17